P043 Aberrant immunophenotype of blasts in low and intermediate-1 risk myelodysplastic syndromes predicts response to growth factor treatment. A prospective clinical phase II study
| Autor: | Westers, T., Alhan, C., Van der Vorst, M., Chamuleau, M., Eeltink, C., Ossenkoppele, G., van de Loosdrecht, A. |
|---|---|
| Zdroj: | In Leukemia Research 2009 33 Supplement 1:S83-S83 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect